Insights

Professional

Practice

Industry

Region

Firm News 25 results

Firm News | 11 min read | 06.05.25

Crowell Attains Leading Rankings in Chambers USA 2025

Washington – June 5, 2025: Crowell & Moring earned 80 rankings for 71 lawyers, as well as 43 national and statewide practice area rankings, in the Chambers USA 2025 guide. The rankings are driven by independent interviews of clients and lawyers at peer firms.

Firm News | 3 min read | 05.30.25

IAM Ranks Crowell & Moring in Patent 1000 2025

Intellectual Asset Management recognized Crowell & Moring in its IAM Patent 1000 – The World’s Leading Patent Practitioners guide, awarding the firm a gold band ranking as one of the top three firms handling patent litigation and transactions in Belgium, and a silver ranking for the firm’s Chicago office. The firm was also recommended nationally in the United States for trade secrets litigation. This marks the twelfth consecutive year that the firm has been ranked in the guide in Belgium.

Firm News | 3 min read | 02.21.25

Crowell & Moring, Planned Parenthood Federation of America, ACLU of Missouri, and ACLU Reproductive Freedom Project Achieve Victory in Reproductive Rights Case in Missouri

Washington – February 21, 2025: Missouri health care providers will be able to resume abortion care after a Jackson County Circuit judge temporarily blocked the Targeted Regulation of Abortion Providers (TRAP) last week. The TRAP restriction, Missouri’s abortion facility licensure requirement, had been left in place in a previous ruling and prevented providers, like Planned Parenthood, from resuming care, despite the state’s voters’ enacting an amendment on November 5, 2024, to enshrine a right to reproductive freedom in the Missouri Constitution. With this ruling, Missouri becomes the first state in the nation to restore abortion access after a total ban.

Client Alerts 64 results

Client Alert | 4 min read | 03.25.25

Federal Circuit Affirms Deductibility of Hatch-Waxman Litigation Expenses

In a significant decision for generic drug manufacturers, the Federal Circuit recently affirmed that litigation expenses incurred in defending Hatch-Waxman patent lawsuits are deductible as ordinary and necessary business expenses under the Internal Revenue Code (IRC). The ruling in Actavis Laboratories FL, Inc. v. United States, No. 23-1320 (Fed. Cir. Mar. 21, 2025), resolves a key tax dispute, allowing tax deductions for these expenses in the year they are incurred rather than capitalizing them over time. This outcome provides clarity and potential tax benefits for qualifying businesses navigating the interplay of patent litigation and FDA drug approvals.

...

Client Alert | 6 min read | 10.23.24

Unfinished Business in Congress on Drug Patents and Competition

Before leaving for an extended recess period ahead of the November general election, Congress left unfinished several proposals with ramifications for generic and biosimilar drug competition. This client alert summarizes some of that legislation and possible next steps in the “lame duck” period before the end of the year.

...

Client Alert | 3 min read | 10.15.24

Can False Claims of Patent Protection Land You in the False Advertising Dawg(s) House?

The Federal Circuit recently held that a claim that a product is protected by patents when it is not may constitute false advertising. Defendants in this case, Dawgs Inc., accused the makers of Crocs of using the terms “patented,” ‘proprietary,” and “exclusive” in its advertising in a manner that misled consumers about the nature, characteristics, or qualities of its own products and the products of its competitors. Specifically, Dawgs alleged that Crocs made promotional statements that a patent covers its Croslite shoe material, that Croslite has numerous tangible benefits found in all of Crocs’ shoe products and that, because Croslite is “patented,” others’ products lack these same benefits. Crocs, Inc. v. Effervescent, Inc., No. 2022-2160, 2024 U.S. App. LEXIS 25001 (Fed. Cir. Oct. 3, 2024).

...

Press Coverage 17 results

Press Coverage | 01.01.25

Patent Policy To Watch In 2025

Press Coverage | 12.13.24

Silence Speaks Volumes As IP Cert Denials Pile Up At US Supreme Court

MLex (subscription required)

Press Coverage | 12.02.24

Lack Of Patent Specialists, Once The Norm, Leaves US District Courts An Outlier

MLex

Publications 16 results

Publication | 10.27.23

How Cos. Can Mitigate IP Risks After NY Labor Law Updates

Law360

Publication | 07.18.23

Can Pharma Firms Deduct Fees In Hatch-Waxman Suits?

Life Sciences Intellectual Property Review

Publication | 02.24.23

Genus Claims Questions After Justices Deny Juno Rehearing

Law360

Events 13 results

Event | 03.22.24, 5:30 PM EDT - 12:00 AM EDT

NYIPLA The 102nd Annual Dinner in Honor of the Federal Judiciary

This event, also known as the “Patent Prom”, celebrates and honors everyone who provides service in the federal judiciary, from the District Courts to Appellate Courts, including Judges, Magistrate Judges, Court Clerks, Law Clerks and their staff. Crowell hosts a cocktail reception as well as a Casino Night. There are approximately 1000 attendees at the black-tie event with many attendees stopping by Crowell’s very popular casino themed reception.

Event | 06.28.23, 6:00 PM EDT - 8:00 PM EDT

NY Women in Licensing Panel

On June 28th, Crowell New York will be hosting NYU’s Women in Licensing group for a panel featuring Dr. Tessa West, NYU Professor and author of Jerks at Work.

Event | 03.09.23, 1:00 PM EST - 2:00 PM EST

Minimizing Risks When Launching Smart Medical Devices

More companies than ever before are launching smart medical devices and industry growth seems endless as new products and technologies are announced daily. However, before companies push products to market, it’s crucial to understand key aspects of device approval, and company and patient protection. In this webinar, our speakers will outline intellectual property strategies, U.S. Food and Drug Administration considerations, and data cybersecurity concerns that are inherent to all smart medical devices. They will explore the legal issues that can significantly decrease the risk profile and potential liabilities throughout a product's lifecycle and create safer, more reliable products for consumers.

...

Webinars 9 results

Webinar | 02.25.25, 1:00 PM EST - 2:30 PM EST

First 100 Days: Navigating New Frontiers: Life Sciences in the Trump Era

Please join us for a post-Election webinar with the heads of our Government Affairs group who will address the myriad of areas in the Life Sciences industry that will likely be impacted by the new administration, including FDA, NIH, drug pricing, imports, and exports.

Webinar | 02.22.24, 12:00 PM EST - 1:00 PM EST

Third Thursday: New York State and Local Employment Law Updates

Please join us for the next edition of Third Thursday – Crowell & Moring’s Labor and Employment Update, a webinar series dedicated to helping our clients stay on top of developing law and emerging compliance issues.

Webinar | 12.20.23, 1:00 PM EST - 2:30 PM EST

IP Assignment Strategies and New State Protections: Key Provisions, Mitigating IP Risks, Implications for Litigation

This CLE will guide counsel on IP assignments and the impact of new state protections that have been put in place. Anne Elise Herold Li and Ira Saxe will compare the requirements of the states that now have additional protections as well as potential litigation. The panel will also provide best practices for assignment strategies.